Truist Financial Sticks to Its Buy Rating for Evolent Health (EVH)
In a report released today, Jailendra Singh from Truist Financial maintained a Buy rating on Evolent Health (EVH – Research Report). The ...
Evolent Health: Health Insurance Headwinds Aren't Helping Business - Rating Downgrade
Evolent Health faces volatility with missed targets and 2024 guidance cuts. Click here for a full investment analysis of EVH ...
Hartford Healthcare Fund Q4 2024 Commentary
The Hartford Healthcare Fund (I share) underperformed the S&P Composite 1500 Health Care Index during the quarter. Read more ...
Barron's3d
Evolent Health Inc. Cl A
Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...
Evolent Health price target raised to $13 from $12 at Citizens JMP
Citizens JMP raised the firm’s price target on Evolent Health (EVH) to $13 from $12 and keeps an Outperform rating on the shares. Evolent’s Q4 ...
Le Lézard4d
Evolent Announces Fourth Quarter and Full Year 2024 Results
Revenue of $646.5 million for the three months ended December 31, 2024 and $2,554.7 million for the year ended December 31, 2024, representing 16.3% and 30.1% growth over 2023, respectively.Net loss ...
Hims & Hers Health (HIMS) To Report Earnings Tomorrow: Here Is What To Expect
Telehealth company Hims & Hers Health (NYSE:HIMS) will be reporting earnings tomorrow afternoon. Here’s what investors should ...
Evolent Health Full Year 2024 Earnings: EPS Beats Expectations
Full Year 2024 Results Key Financial Results Revenue: US$2.55b (up 30% from FY 2023).
TipRanks on MSN6d
Evolent Health’s AI Strategy: Navigating Risks and Challenges Amidst Technological Advancements
Evolent Health Inc. (EVH) has disclosed a new risk, in the Technology category. Evolent Health Inc. faces significant risks associated with its ...